Similarly, in experimental sepsis, intravenous injection of MSCs reduce inflammation, enhance bacterial clearance and improving survival20, while IGF-1 treatment was also found to improves survival in sepsis via decreased bacterial translocation42. This evidence concerns the gene IGF1 and Sepsis.